The Revista Brasileira de Cirurgia Plástica/Brazilian Journal of Plastic Surgery (RBCP/BJPS) is the official scientific publication of the Brazilian Society of Plastic Surgery (SBCP). All costs related to article processing charges (APCs) are covered by the Society; therefore, there are no fees or charges for submission, review, translation, or publication of articles. The electronic format of the journal, e-ISSN 2177-1235, operates under a continuous publication model.

The Journal aims to record scientific production in Plastic Surgery, fostering study, improvement, and continuing education for specialists in the field. Manuscripts submitted for publication in the Journal must address topics related to Plastic Surgery and related areas. The journal publishes the following article categories: Editorial, Original Article, Review Article, Case Report, Ideas and Innovations, Special Article, and Letter to the Editor.
The entire process is carried out electronically, and authors must declare that they are aware of the copyright licenses that will take effect if the manuscript is accepted and published in the RBCP. The copyright policy adopted by the journal expands access to knowledge by allowing articles to be published in an open access format without the need for prior registration. Articles are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0), which authorizes users to read, download, copy, distribute, and use the content for any lawful purpose, provided that proper credit is given to the authors and the journal.
RBCP is indexed in the LILACS, DOAJ, SciELO, and Scopus databases.

 

HOW TO CONTACT THE JOURNAL

Revista Brasileira de Cirurgia Plástica (Brazilian Journal of Plastic Surgery)
Funchal Street, 129, 2nd floor - Vila Olímpia
São Paulo - SP - Brazil – Zip Code 04551-060
Phone: 55 11 3044-0000 - Cell Phone: 55 11 99661-4366
E-mail: rbcp@cirurgiaplastica.org.br
Website: www.rbcp.org.br

 

ARTICLE CATEGORIES

Editorials - Written by the Editorial Board or commissioned from renowned specialists in the field, addressing topics of relevance to the journal and the specialty. The Editorial Board may, on occasion, consider the publication of editorials submitted spontaneously.

Original Article - This category includes experimental clinical studies, controlled trials, randomized studies, observational studies, case series, as well as basic research. Original articles must be structured and must contain Introduction, Objective, Methods, Results, Discussion, Conclusion, References, and Abstract. The text should contain a maximum of 3000 words, excluding tables, references, and abstract. The number of references should not exceed 30, the number of figures is limited to 20 images, and the number of tables is limited to 4.

Review Article - This category accepts systematic and non-systematic reviews related to topics relevant to the specialty. Review articles should contain a maximum of 3000 words, excluding references. The maximum number of tables allowed is 6, as well as a limit of 6 images, presented individually or grouped. References should be current, preferably published within the last five years, with a maximum of 40 citations.

Case Report - The text should include Introduction, Case Description, Discussion, Conclusion, and References. The word count is limited to 1000, excluding references and tables. References are limited to 10. A maximum of 8 images may be included, presented individually or grouped.

Ideas and Innovations - Studies that are original and innovative in nature, not exceeding 1000 words, 10 references, and 8 images presented individually or grouped. The body of the article should include: Introduction, Methods, Results, Discussion, Conclusion, and References.

Special Article - Articles that cannot be classified in the previously described categories, which the Editorial Board deems to be of special relevance to the specialty. Their review follows specific criteria, with no limitations on length or restrictions on the number of references.

Letter to the Editor - Comments, discussion, or criticism of articles published in the Revista Brasileira de Cirurgia Plástica, as well as other topics of general interest. The maximum recommended length is 250 words, and it may contain up to 5 references. Whenever appropriate and possible, a reply from the authors of the article under discussion will be published alongside the letter.

 

EDITORIAL POLICY

The entire process is conducted through the electronic submission system. The review system is double-anonymized, ensuring anonymity throughout the entire evaluation process.

Peer review

Prior to publication, all manuscripts submitted to the Revista Brasileira de Cirurgia Plástica undergo a review and arbitration process to ensure quality standards and impartiality in the selection of works to be published. Before content evaluation, the article is assessed for format to verify compliance with the evaluation guidelines and completeness.
All manuscripts are submitted in anonymized form for peer review. Acceptance is based on originality, significance, and relevance of scientific contribution. Reviewers complete a form in which they rigorously evaluate the items comprising the study. Reviewers provide comments on the study and give individual opinions, recommending corrections or acceptance of the work. Constructive criticism aimed at improving study is encouraged. The Editor-in-Chief is responsible for the final decision based on the reviewers’ assessments; in case of discrepancies, the editor may request additional revisions. When modifications are suggested by the reviewers, these are forwarded to the authors, who are given a new deadline to analyze and respond to the journal, providing justifications for the comments along with submission of an updated version of the article. This resubmission may be evaluated by new reviewers in addition to the initial reviewers. When the subject matter of the manuscript so requires, the editor may request the collaboration of a professional not listed on the Editorial Board to perform the evaluation (ad hoc reviewers). Regardless of acceptance or rejection of the study, authors have full access to the evaluations and forms, made available in the electronic submission system. The dates of receipt and approval of the article for publication are provided in the published article in order to respect the authors’ priority interests. RBCP recommends that its editors and reviewers adhere to relevant best practice guidelines on peer review and follow the guidelines proposed by the COPE Ethical Guidelines for Peer Reviewers, available at: https://publicationethics.org/resources/guidelines-new/cope-ethical-guidelines-peer-reviewers.

 

Openness in peer review
 
The RBCP, following the recommendations of good practices in open science and transparency in evaluations, supports open peer review, making it possible to include in the approved article: the name of the editor responsible for evaluating the manuscript; to offer the referees and the corresponding author the opening of their respective identities; offer reviewers the option of publishing the review in the journal as a communication identified with DOI and capable of being indexed and cited with or without identifying the reviewer as the author.

 

Research with Humans and Animals

Manuscripts submitted without the attached approval of the Research Ethics Committee and/or the Informed Consent Form (informed consent) will not be considered for publication in the journal.
Research involving humans or animals must be approved by Research Ethics Committees (CEP) and must comply with international ethical and legal standards for research. Authors must respect the right to privacy of human participants and obtain the necessary consent for publication prior to submission.
Research projects involving human subjects must comply with the Declaration of Helsinki, revised in 2013 (https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/), and studies conducted in Brazil must follow Resolutions No. 466/2012 (http://conselho.saude.gov.br/resolucoes/2012/Reso466.pdf) and No. 510/2016 (http://conselho.saude.gov.br/resolucoes/2016/Reso510.pdf) of the Brazilian National Health Council, in addition to Circular Letter No. 166/2018 (http://conselho.saude.gov.br/images/comissoes/conep/documentos/CARTAS/CartaCircular166.pdf).
Investigations involving animal models must comply with the rules applicable to such procedures, as specified in the Basel Declaration (www.basel-declaration.org), the ARRIVE guidelines – Animal Research: Reporting of In Vivo Experiments (https://arriveguidelines.org/arrive-guidelines), and the Guide for the Care and Use of Laboratory Animals (Institute of Laboratory Animal Resources, National Academy of Sciences, Washington, USA). The Editorial Board of the Journal will reject articles that do not strictly adhere to the ethical principles of research, whether in humans or animals. Authors must precisely identify all drugs and chemical substances used, including the names of active ingredients, dosages, and routes of administration. They must also avoid trade names or company names.

 

Policy for Clinical Trial Registration

The Revista Brasileira de Cirurgia Plástica supports the clinical trial registration policies of the World Health Organization (WHO) and the International Committee of Medical Journal Editors (ICMJE), recognizing the importance of these initiatives for the registration and international dissemination of information on clinical studies in open access. Accordingly, clinical trials are only acceptable if properly registered before the start of data collection at www.clinicaltrials.gov or an equivalent international repository. The registration number must be included at the end of the abstract.
RBCP adopts the definition of clinical trial recommended by the WHO, which can be summarized as follows: "any research study that prospectively assigns human participants to one or more interventions aimed at evaluating their effects on health-related outcomes. Interventions include drugs, cells, and other biological products, surgical procedures, radiological procedures, devices, behavioral therapies, changes in care processes, preventive care, etc."

Authorship and Contribution Criteria

The criteria for authoring the articles should follow the recommendations of the International Committee of Medical Journal Editors (http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and- contributors.html). Only individuals who have contributed directly to the intellectual content of the work should be listed as authors. Authors must satisfy all of the following criteria to be able to have public responsibility for the content of the work:
1. Have conceived and planned the activities that led to the work or interpreted the results to which they arrived, or both;
2. Have written the work or revised the successive versions and participated in the review process;
3. Have approved the final version;
4. Agree to be responsible for all aspects of the work and ensure that issues related to the accuracy or integrity of any part of the work are properly investigated and resolved.

We consider the corresponding author to be the person who handles the manuscript and is responsible for correspondence during the publication process. We request that the corresponding author confirm that he has the authority to act on behalf of all co-authors in all matters relating to the publication of the manuscript, including supplementary material. The corresponding author is responsible for obtaining such agreements and informing co-authors of the manuscript's status during the submission, review and publication process. In addition, the corresponding author is the main contact for any questions (including those related to the work's integrity) after the publication of the article.

It is mandatory to include the ORCID ID registration number for all authors. (https://orcid.org/signin).

The Committee on Publication Ethics (Cope) also provides comprehensive resources on authorship and authorship disputes, and we recommend everyone involved in editorial decisions become familiar with these resources.

We have adopted initiatives that allow transparency in authorship and contribution, such as the CRediT taxonomy.

Individuals who do not meet the above criteria and who have provided technical assistance or general support may be acknowledged in the Acknowledgments section.

Preprints

RBCP accepts the submission of manuscripts previously deposited in preprint servers recognized by the journal and in institutional or subject repository. Preprints are manuscripts ready for submission to a journal and are deposited on an open access web server prior to or in parallel with journal submission for evaluation for formal publication as a peer-reviewed article.

 

Plagiarism and Duplicity

Plagiarism
Plagiarism is defined as "using ideas, words, data or other material produced by another person without recognition".
Plagiarism can occur concerning all types of sources and means of communication, including:
• text, illustrations, musical quotes, extended mathematical derivations, computer code, etc .;
• material downloaded from websites or taken from manuscripts or other media;
• published and unpublished material, including lectures, presentations and gray literature.
RBCP does not tolerate plagiarism in any of its publications and reserves the right to screen all submissions using Similarity Check / iThenticate (http://www.ithenticate.com) to ensure originality.
Submissions that show evidence of plagiarism, in whole or in part, will be rejected. If plagiarism is discovered after publication, we will issue a retraction in accordance with the COPE Retraction Guidelines (https://publicationethics.org/retraction-guidelines). We encourage our readers, reviewers, and editors to report any suspected plagiarism by sending an email to rbcp@cirurgiaplastica.org.br.

Duplicate and redundant publishing
Duplicate or redundant publication, or "self-plagiarism," occurs when a work, or substantial parts of a work, is published more than once by the author(s) of the work without proper cross-referencing or justification for the overlap, regardless of the language used.
We do not support substantial overlap between publications, unless:
• it is considered that, editorially, this will strengthen the academic discourse;
• have the explicit approval of the original publication;
• Include a quote from the original source.
We instruct our readers, reviewers, and editors that, in the presence of any suspicion of duplicate or redundant publication, they should send an email to rbcp@cirurgiaplastica.org.br.
When a study is submitted to RBCP, the manuscript must not be under consideration, accepted for publication, or in press in a different journal, book, or similar entity.

Use of Artificial Intelligence (AI) in Scientific Publications

The Journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations regarding artificial intelligence (AI) tools. AI cannot meet the authorship criteria, as it cannot take responsibility for the work. Therefore, no AI tool or machine learning system may be listed as an author or coauthor.
If AI technologies (e.g., large language models, chatbots, text/image generation, or data analysis tools) are used in the research or manuscript preparation, authors must provide full transparency. The use must be described in the Methods, Acknowledgments, or a specific statement, including:

• the name, version, and manufacturer of the tool;
• the purpose of use;

-     the extent of use.
Authors are fully responsible for the submitted content, regardless of AI use. Manuscripts that do not adequately declare AI use or that attribute authorship to AI tools may be rejected.

 

Conflicts of Interest and Financing

We ensure that any publication in the Brazilian Journal of Plastic Surgery is free from undue influence. Authors submitting a manuscript must declare any potential conflicts of interest that could interfere with the objectivity or integrity of the publication, stating whether the authors' institution at any time received payment or services of any kind from third parties for the submitted work (including, but not limited to, funds, data monitoring committee, study design, manuscript preparation, statistical analysis, financial support for attending meetings related to the study or other reasons, consulting fees or honoraria, payment for manuscript writing or review, etc.).
Conflicts of interest are situations that may exert undue influence on the presentation, review, or publication of a work. They may be financial, non-financial, professional, contractual, or personal in nature. A statement of potential conflicts of interest must be included with the submitted manuscript, indicating all authors who participated in the study (including main authors and coauthors). If no authors have any conflicts of interest, the manuscript must include the statement: "The authors declare no conflicts of interest." Please visit http://www.icmje.org/conflicts-of-interest to download the ICMJE conflict of interest form. Disclosure information is essential for article processing; incomplete or missing forms may delay publication.
We also encourage anyone who suspects an undisclosed conflict of interest regarding a work published in RBCP to inform us by sending an email to rbcp@cirurgiaplastica.org.br.

 

Language

Submissions are accepted in English or Portuguese. They must follow current spelling conventions, using clear, technical, and precise language, avoiding the informality of colloquial language. If an English version already exists, it may be submitted together with the Portuguese version. Articles are published in both Portuguese and English, in XML and PDF formats.

Retractions and Errata

The journal's editors will consider retractions and errata following COPE's Retraction Guidelines (https://publicationethics.org/retraction-guidelines). If it is found that the author or RBCP made an error, the magazine will issue an errata. Retractions are generally reserved for articles with flaws so serious that their findings or conclusions should not be trusted. Manuscripts accepted by RBCP may contain minor changes, such as those that would likely occur during typesetting or review, but any substantive corrections will be made in accordance with the COPE Retraction Guidelines.

 Image Manipulation, Counterfeiting and Fabrication

 When research data are collected or presented as images, modification of these images may sometimes misrepresent the results obtained or their meaning. We acknowledge that there may be legitimate reasons to modify images, but we recommend that authors avoid altering images when this could lead to suspicion of falsification, fabrication, or misrepresentation of their findings.

 Fraudulent Research and Misconduct in Research
 
When we are informed of fraudulent research or research misconduct by an author of the Revista Brasileira de Cirurgia Plástica, our primary concern is the integrity of the published content. The Editor, co-editors, and associate editors will open an investigation to ascertain the facts. Any publication that contains fraudulent results will be withdrawn, or an errata will be issued. See the Disclaimers and Errata section of these guidelines for more information.

 Versions and Adaptations

The RBCP does not modify existing published content, nor does it originate new materials to meet political or ideological requirements when we believe that these compromise the quality, effectiveness or accuracy of the materials or conflict with our Code of Ethics. We grant volume licenses and subsidiary rights to third parties that allow the reproduction, reuse or adaptation of our content in different contexts, languages ??and territories. When we license volume rights, our authors and we retain the right to refuse approval for publication if we doubt the integrity and accuracy of the licensed edition.

Slander, Defamation and Freedom of Speech

Freedom of expression is fundamental in academic publishing, but we do not support the publication of false statements that damage the reputation of individuals, groups or organizations. Our legal team can advise on defamation reviews before publication and deal with any defamation allegations eventually published in the RBCP.

Transparency

We strive to follow COPE's Principles of Transparency and Best Practices in Academic Publications (https://publicationethics.org/resources/guidelines-new/principles-transparency-and-best-practice-scholarly-publishing) and encourage our publication partners to defend these same principles.
Authors are encouraged to make available all content (data, program codes and other materials) underlying the manuscript text before or at the time of publication through a Data Availability Declaration that must be entered into the RBCP submission system. The Data Availability Statement should signal where the data associated with a document is available and under what conditions (licenses) the data can be accessed, including links (where applicable) to the dataset. Exceptions are allowed in cases of legal and ethical issues. The objective is to facilitate the evaluation of the manuscript and, if approved, to contribute to the preservation and reuse of the contents and the reproducibility of the research. The initiative increases transparency, enables compliance with data policies, encourages good scientific practice and trusts in published studies.

Registry Integrity

We keep a record of the existence of everything we publish with information (metadata) that describes each publication. Whenever we have to change the publication record, as in the case of research misconduct leading to retraction of a publication, we preserve the academic record as far as possible.
We apply these same principles to our marketing and do not modify or manipulate publications in our marketing activities.
When an article is accessed on our portal (www.rbcp.org.br), we provide it only in its entirety, and we do not grant the right to alter its content in a way that is inconsistent with the licensing terms under which it was published.

 Marketing Communication
 
Social media and e-mail communication are powerful tools to disseminate and interact with our publications, reach new readers, and keep content alive. However, such communication should not be made at the expense of the integrity of the content. We reserve the right to reject or remove any ad when we doubt that it violates these Research Publication Ethics Guidelines. We also advertise our products and services to customers. We do this following our Privacy Policy, data protection regulations, the Advertising Standards Authority Guidance on Publication Marketing and our internal compliance procedures.

Final considerations

Other decisions regarding the ethics, misconduct, and integrity of scientific research are based on the Code of Conduct guidelines for Journal Editors (COPE), available at http://publicationethics.org/files/Code_of_conduct_for_journal_editors_Mar11.pdf, and the World Association of Medical Editors (WAME), available at http://www.wame.org.

 

MANUSCRIPT PREPARATION

The journal adopts the Vancouver style - Uniform Requirements for Manuscripts Submitted to Biomedical Journals, organized by the ICMJE - "Vancouver Group" (http://www.icmje.org/recommendations/browse/manuscript-preparation). Compliance with these instructions is mandatory for the study to qualify for analysis.

Title page
Write the title of the article concisely in Portuguese and English. Write the authors' full names with their affiliations (Institution, Faculty and Department, City, State and Country), the authors' ORCID registration numbers and email addresses. Also inform the name, address and telephone number of the corresponding author. Potential conflicts of interest and funding sources must be declared.  Declare potential conflicts of interest and sources of funding. Please list up to eight authors and specify their contribution to the study. Authors are researchers who contributed substantially to the conception and design and/or data analysis and interpretation, drafted the manuscript or reviewed it critically for intellectual content, and approved the final manuscript.

Abstract in English and Portuguese (only for Original Article, Special Article, Review Article, and Case Report)
The abstracts of Original Articles should contain Introduction, Method, Results, and Conclusions. The abstracts should explain the study's main findings without the need to resort to the main text. Write an abstract in English containing the following sections: Introduction, Methods, Results, and Conclusions. This abstract should be a faithful translation of the Portuguese abstract. For Review Articles and Case Reports, write unstructured abstracts in English and Portuguese. Abstracts should not exceed 250 words.
Keywords
Include five to ten keywords, in Portuguese and English. The descriptors should be based on the Health Sciences Descriptors (Descritores em Ciências da Saúde–DeCS) published by Bireme, which are translations of the Medical Subject Headings from the National Library of Medicine (NLM), https://www.nlm.nih.gov/mesh/meshhome.html.

Main text
The text must be typed in double space, font Arial, size 12, margin 2.5cm on each side. The number of sections depends on the article category. Cite references as superscripts in the order of citation in the main text. Abbreviations and acronyms must be preceded by the terms in full, when mentioned for the first time in the text, and must not be used in the title and abstract. Abbreviations in the legends of tables and figures must be accompanied by their meaning.

The Introduction section should describe the purpose and rationale of the study and establish the study's theoretical basis. Indicate the importance of the study, and identify flaws or inconsistencies in the literature and/or difficulties in clinical practice that make the study relevant to the specialist.

The Objective section should indicate the purpose of the study clearly and concisely in one paragraph.

The Method section comprises observational and experimental elements, such as patients, laboratory animals, controls, inclusion and exclusion criteria when appropriate, and sufficient details to allow data reproduction in other studies. Add references for published but unfamiliar methods and describe new techniques in detail. Indicate the study period and study site(s) and the statistical methods and computer software used.

Authors should declare that the study was approved by the Research Ethics Committee of the Institution where the work was carried out and include the registration number in the text. (A copy of the study's approval by the Institutional Ethics Committee must be attached as a document to the submission.)

The Results section the author is expected to compare the results obtained in their study with existing data in the literature, demonstrating knowledge and critical judgment regarding their work. Comments should relate to the scope, positioning, and correlation of the study with others in the literature, as well as include study limitations and future perspectives.

The Discussion section demonstrates knowledge and critical thinking and compares the obtained results with literature data. The scope and points of view of the study and the limitations and future perspectives should be described.

The Conclusions section should be concise and related to the proposed objectives.

The Acknowledgments section should be presented at the end of the text and contain the names of collaborators who contributed intellectually or technically to the research but did not meet the criteria for authorship and funding agencies.

References
References must be up to date, and we recommend prioritizing the last 5 years, with the exception of classic or relevant articles to the study. Cite the consulted references in Arabic numerals in superscript in the order of citation in the text. List the names of up to six authors; for references with more than six authors, cite the first six followed by et al. Present the references in the Vancouver style and abbreviate the journal titles according to the List of Journal Indexed in Index Medicus from the NLM. Different types of bibliographic references are shown below; other examples are available at the NLM website (http://www.ncbi.nlm.nih.gov/nlmcatalog/journals).

Article
Quintas RC, Coutinho AL. Risk factors for the impairment of surgical margins in resections of basal cell carcinomas. Rev Bras Cir Plást. 2008;23(2):116-9.
Book Chapter
D'Assumpção EA. Problems and solutions in rhytidoplasties. In: Melega JM, Baroudi R, eds. Plastic surgery fundamentals and art: cosmetic surgery. Rio de Janeiro:Medsi;2003. p.147-65.
Book
Saldanha O. Lipoabdominoplasty. Rio de Janeiro:Di Livros; 2004.
Thesis
Freitas RS. Jawbone elongation using an internal device: quantitative analysis of the results [doctoral thesis]. São Paulo: University of São Paulo Medical School; 2003. 97p.
Events
Carreirão S. Reduction mammoplasty. In: XXXVI Brazilian Congress of Plastic Surgery; November 11-16, 2001; Rio de Janeiro, Brazil.

Tables
Tables must be numbered sequentially in Arabic numerals, in the order in which they are cited in the text. A maximum of 4 tables is accepted. All tables must have a title and column headings and must be cited in the text. In the table footer, a legend for abbreviations and statistical tests used must be included.
Tables should present data necessary for the effective understanding of the work, and should not contain redundant information already mentioned in the text.

Figures      
All figures (graphs, photographs, illustrations) must be numbered sequentially in Arabic numerals, following their order of citation.
Figures must be accompanied by their respective legends. Legends should be submitted as a separate list from the images. Abbreviations used in figures must be explained in the legends.

The number of figures may not exceed 20 individual figures for original articles. An individual figure is understood as each image attached to the study; for example, figure 1 (A, B, C, D) will count as 4 figures out of the 20 accepted.
Patient photos must have a uniform background (especially background color and without any extraneous objects appearing: doorknobs, light fixtures, etc.). The photographed field must be restricted to the area of interest. In facial photos, use available resources to prevent patient identification. In any case where patient images are used, the author must attach an individualized authorization for the use of images. If the figures have already been published, they must be accompanied by written permission from the author/publisher, with the original publication source stated in the figure legend.

Image resolution should comply with the following criteria:



• Image 1: Di Lamartine J, Cintra Junior R, Daher JC, Cammarota MC, Galdino J, Pedroso DB, et al. Reconstruction of the nipple-areola complex with double opposing flap. Rev Bras Cir Plást. 2013;28(2):233-40.
• Image 2: Alves JC, Fonseca RP, Silva Filho AF, Andrade Filho JS, Araujo IC, Almeida AC, et al. Extended resection in the treatment of dermatofibrosarcoma protuberans. Rev Bras Cir Plást. 2014;29(3):395-403.
• Image 3: Alves JC, Fonseca RP, Silva Filho AF, Andrade Filho JS, Araujo IC, Almeida AC, et al. Extended resection in the treatment of dermatofibrosarcoma protuberans. Rev Bras Cir Plást. 2014;29(3):395-403.

Font: Adapted from http://www.ncbi.nlm.nih.gov/pmc/pub/filespec-images/#fig-format

 

MANUSCRIPT SUBMISSION

Manuscripts must be submitted electronically via the website www.rbcp.org.br. Initial registration must precede the submission of the study. If the authors have already registered, it is necessary to log in to the system, following the instructions provided on the website. Texts, figures, tables, and additional documents must be uploaded to the respective fields in the electronic submission system.

 

DECLARATIONS AND DOCUMENTS

Following the guidelines of the ICMJE, the following documents and statements should be uploaded together with the manuscript:

• Submission Letter addressed to the Editor-in-Chief, containing information about the most important findings and conclusions of the manuscript, clarifying its relevance to the scientific community. The cover letter must also state that the manuscript has not been previously published and has not been submitted for publication in another journal;
• A text document containing the authors' ORCID registration numbers, affiliations, the institution(s) where the study was conducted, and the address of the corresponding author.;
• Declaration of Potential Conflicts of Interest (document generated in the electronic system before manuscript submission). Conflicts of interest include the employment, sponsorship, or funding of any person or institution, public or private, with economic interests in the article's content. This statement will be added to the published article;
• Approval of the study by the Research Ethics Committee of the institution where the work was carried out, and attachment of the protocol number and name of the said committee;
• Informed Consent Form, when referring to research articles involving human beings;
• Image use authorization term;
• Copyright and permission to reproduce materials. Agreeing to the following terms:
• Authors retain copyright and grant RBCP the right of first publication;
• Authors have the right to share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material for any purpose, even commercial).

RBCP adopts the Creative Commons Attribution 4.0 International license (CC BY 4.0): https://creativecommons.org/licenses/by/4.0

(Declarations and complementary documents must be included in the electronic submission system in the 'Attachments' field’).

The journal adopts an open access publication model, and submissions occur entirely in electronic format at: https://mc.manuscriptcentral.com/rbcp. Through this link, authors will be guided step by step through the creation and upload of various files. Use the guidelines to prepare your manuscript. All correspondence, including notification of the Editor's decision and requests for revisions, will occur via email and through the author's homepage within the submission system itself.

 

ARTICLES ACCEPTED FOR PUBLICATION

Once accepted for publication, a proof of the edited article (PDF format) is sent to the corresponding author for evaluation and approval. Articles are accepted immediately in the continuous publication format.

 

CHECKLISTS

Before submitting the manuscript, authors should refer to the following checklist according to the article category:
•          CONSORT (CONsolidated Standards of Reporting Trials) checklist and flowchart for controlled and randomized trials (http://www.consort-statement.org/)
•          STARD (Standards for Reporting of Diagnostic Accuracy) checklist and flow chart for studies of diagnostic accuracy (http://www.stard-statement.org/)
•          PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) checklist and flowchart for systematic reviews (http://www.prisma-statement.org/)
•          CARE (diretrizes para CAse REports) checklist and flowchart for case reports (https://www.care-statement.org/checklist)
•          STROBE checklist for observational studies in epidemiology (http://www.strobe-statement.org/index.php?id=strobe-home)

• SciELO good practice guidelines for strengthening ethics in scientific publishing (https://wp.scielo.org/wp-content/uploads/Guia-de-Boas-Praticas-para-o-Fortalecimento-da-Etica-na-Publicacao-Cientifica.pdf)